Document Detail


When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy.
MedLine Citation:
PMID:  20647527     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Juvenile myoclonic epilepsy is one of the most common types of epilepsy seen in an adult epilepsy clinic. Most patients have a good prognosis, particularly when treated with valproate, but a significant minority are more difficult to treat. In this article, we will focus on a management strategy when the initial antiepileptic drug is unsuccessful and outline an approach that translates directly to the clinic.
Authors:
Andrew Nicolson; Anthony G Marson
Related Documents :
2289477 - The role of technical, biological and pharmacological factors in the laboratory evaluat...
23345437 - Hydrogel drug delivery system with predictable and tunable drug release and degradation...
24204397 - Concurrent use of hypnotic drugs and chinese herbal medicine therapies among taiwanese ...
20187347 - The management of seizures in brain tumor patients.
12481827 - Cellular impermeability and uptake of biocides and antibiotics in gram-negative bacteria.
12713667 - Clinical and outcome research in oncology. the need for integration.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Practical neurology     Volume:  10     ISSN:  1474-7766     ISO Abbreviation:  Pract Neurol     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101130961     Medline TA:  Pract Neurol     Country:  England    
Other Details:
Languages:  eng     Pagination:  208-18     Citation Subset:  IM    
Affiliation:
The Walton Centre NHS Foundation Trust, Lower Lane, Fazakerley, Liverpool L9 7LJ, UK. andrew.nicolson@thewaltoncentre.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Do CSF biomarkers help clinicians predict the progression of mild cognitive impairment to dementia?
Next Document:  Epilepsy: creative sparks.